Skip to main content
CivicGate

HRES 396
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Expressing support for the designation of the week of May 4, 2025, through May 10, 2025, as "Tardive Dyskinesia Awareness Week".

Expressing support for the designation of the week of May 4, 2025, through May 10, 2025, as ``Tardive Dyskinesia Awareness Week''.

Introduced May 7, 2025

Latest action (May 7, 2025) Referred to the House Committee on Energy and Commerce.

Policy area
Issues
Healthcare

Summary

This resolution expresses the House of Representatives' support for designating the week of May 4-10, 2025, as "Tardive Dyskinesia Awareness Week" and encourages individuals in the United States to become better informed about tardive dyskinesia. Tardive dyskinesia is an involuntary movement disorder that can develop as a side effect of prolonged use of certain psychiatric and gastrointestinal medications, and it affects an estimated 600,000 people in the United States, with approximately 65 percent remaining undiagnosed. The resolution notes that FDA-approved treatments for tardive dyskinesia are available and that regular screening is recommended by the American Psychiatric Association.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Money behind the sponsor

Top reported contributors to Scott H. Peters’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • RA CAPITAL MANAGEMENT $19,800
  • BLACKSTONE $17,500
  • GENERAL ATOMICS $15,400
  • QUALCOMM $13,300
  • RA CAPITAL $13,200

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Scott H. Peters → · Outside spending →

Actions (2)

  1. May 7, 2025 Referred to the House Committee on Energy and Commerce. · house
  2. May 7, 2025 Submitted in House

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Full text

IN THE HOUSE OF REPRESENTATIVES

May 7, 2025

Mr. Peters (for himself, Mr. Bilirakis, Mr. Mullin, and Mr. Bean of Florida) submitted the following resolution; which was referred to the Committee on Energy and Commerce

RESOLUTION

Expressing support for the designation of the week of May 4, 2025, through May 10, 2025, as “Tardive Dyskinesia Awareness Week”.

Whereas many people living with serious mental illnesses (for example, bipolar disorder, major depressive disorder, schizophrenia, and schizoaffective disorder) or gastrointestinal disorders (for example, gastroparesis, upset stomach, nausea, and vomiting) may be treated with medications that work as dopamine receptor blocking agents, including antipsychotics and antiemetics; Whereas, while ongoing treatment with these medications can be necessary, prolonged use may be associated with tardive dyskinesia (TD), an involuntary movement disorder that is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, and fingers or toes; Whereas even mild symptoms of TD can impact people physically, socially, and emotionally; Whereas it is estimated that TD affects approximately 600,000 people in the United States, and approximately 65 percent of people with TD have not been diagnosed, making it important to raise awareness about the symptoms; Whereas it is important that people taking these medications be monitored for TD by a health care provider, and regular screening for TD is recommended by the American Psychiatric Association; Whereas clinical research has led to approval of treatments for adults with TD by the Food and Drug Administration, and recognition and treatment of TD can make a positive impact in the lives of many people experiencing psychotic and mood disorders; and Whereas the House of Representatives can raise awareness of TD among the public and medical community: Now, therefore, be it Resolved, That the House of Representatives—

(1) expresses support for the designation of “Tardive Dyskinesia Awareness Week”; and

(2) encourages each individual in the United States to become better informed about and aware of tardive dyskinesia. <all>

Comments

Comments

Loading comments…